Source:http://linkedlifedata.com/resource/pubmed/id/20227773
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2010-4-12
|
pubmed:abstractText |
Neuromyelitis optica (NMO) is a devastating neuroinflammatory disorder that specifically targets the spinal cord and optic nerves. Aquaporin-4 (AQP4) is the target of the NMO-IgG biomarker. AQP4 is expressed as two isoforms: M1 and M23, which have different functions in the central nervous system (CNS). We characterized the expression pattern of these AQP4 isoform mRNAs in humans and found a pattern of AQP4 expression that correlates with NMO disease localization. The ratio of M1:M23 mRNA is highest in the optic nerve and spinal cord, followed by brainstem, then the cerebral and cerebellar cortices.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1872-8421
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2010 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
221
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
68-72
|
pubmed:meshHeading |
pubmed-meshheading:20227773-Aquaporin 4,
pubmed-meshheading:20227773-Central Nervous System,
pubmed-meshheading:20227773-Female,
pubmed-meshheading:20227773-Gene Expression Regulation,
pubmed-meshheading:20227773-Humans,
pubmed-meshheading:20227773-Male,
pubmed-meshheading:20227773-Middle Aged,
pubmed-meshheading:20227773-Neuromyelitis Optica,
pubmed-meshheading:20227773-Postmortem Changes,
pubmed-meshheading:20227773-Protein Isoforms,
pubmed-meshheading:20227773-RNA, Messenger
|
pubmed:year |
2010
|
pubmed:articleTitle |
Differential expression of aquaporin-4 isoforms localizes with neuromyelitis optica disease activity.
|
pubmed:affiliation |
Department of Neurology, Johns Hopkins University, Baltimore, MD 21205, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|